tiprankstipranks
Company Announcements

Matinas BioPharma Chairman Eric Ende Resigns

Story Highlights
Matinas BioPharma Chairman Eric Ende Resigns

Matinas BioPharma ( (MTNB) ) just unveiled an announcement.

On March 13, 2025, Eric Ende announced his resignation from the Board of Directors and as Chairman of Matinas BioPharma, effective March 14, 2025, due to other professional commitments. His departure was not due to any disagreement or shift in the company’s direction, indicating stability in the company’s strategic focus and operations.

More about Matinas BioPharma

Matinas BioPharma is a company operating in the biopharmaceutical industry, focusing on the development of innovative therapies and products.

YTD Price Performance: -10.51%

Average Trading Volume: 469,999

Technical Sentiment Consensus Rating: Strong Buy

Current Market Cap: $2.72M

See more insights into MTNB stock on TipRanks’ Stock Analysis page.

Questions or Comments about the article? Write to editor@tipranks.com

Questions or Comments about the article? Write to editor@tipranks.com
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App